-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationFan Dongdong
Recently, the FDA cancelled Bayer Astepro's prescription requirements for seasonal and year-round allergic rhinitis.
Benefiting from the latest FDA approval, starting early next year, American patients will be able to purchase the nasal spray to relieve allergic symptoms without a prescription
The shift from pharmacies to retail stores also represents a popular strategy for manufacturers to participate in consumer health
Glaxo Smith Kline seems to have made a similar move
For Bayer, its consumer health business grew strongly last year, with sales reaching 5.
As part of a substantial group-wide adjustment initiated by Baumann at the end of 2018, Bayer has been realigning its priorities in the consumer health sector
Reference source: No more prescriptions: Bayer gets FDA nod to provide allergy nasal spray over the counter